NDAORALCAPSULE, DELAYED REL PELLETS
Approved
Jul 2019
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Data completeness
7/8 — Comprehensive
DRIZALMA SPRINKLE (duloxetine) by Fosun Pharma is antidepressant, central pain inhibitory and anxiolytic actions of duloxetine in humans are unknown, these actions are believed to be related to its potentiation of serotonergic and noradrenergic activity in the cns. Approved for major depressive disorder, generalized anxiety disorder, fibromyalgia and 2 more indications. First approved in 2019.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DRIZALMA SPRINKLE is a delayed-release capsule formulation of duloxetine, an SNRI antidepressant that potentiates serotonergic and noradrenergic activity in the CNS. It is indicated for major depressive disorder, anxiety disorders, fibromyalgia, chronic pain conditions, and stress urinary incontinence. The sprinkle formulation enables flexible dosing by allowing capsules to be opened and contents sprinkled on food.
$0.009BPart D
Peak10.9 years to LOEProduct is at peak commercial stage with minimal Medicare Part D penetration, suggesting early-stage market adoption or niche positioning within duloxetine franchise.
Mechanism of Action
antidepressant, central pain inhibitory and anxiolytic actions of duloxetine in humans are unknown, these actions are believed to be related to its potentiation of serotonergic and noradrenergic activity in the CNS.
Indications (5)
Worked on DRIZALMA SPRINKLE at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.